Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06099886
PHASE1

Repurposing Lithium for Parkinson's Disease

Sponsor: State University of New York at Buffalo

View on ClinicalTrials.gov

Summary

This study will examine the effects of lithium aspartate 30-45mg/day on MRI biomarkers and blood-based therapeutic targets among 15 early-stage Parkinson's disease patients.

Official title: Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Phase I Trial

Key Details

Gender

All

Age Range

45 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2023-10-12

Completion Date

2025-04-30

Last Updated

2026-04-14

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Lithium aspartate

Lithium aspartate 30-45mg/day

Locations (1)

University at Buffalo

Williamsville, New York, United States